Fourth Quarter 2015 Gains for Companies

摘要

Bio-Rad Sees Improved Research Spending Fourth quarter 2015 sales for Bio-Rad Laboratories Life Science (LS) contracted 2.5% to $218.1 million to account for 38% of revenues. However, excluding currency, organic sales advanced 3.4%, led by demand for digital PCR, process media, cell biology and western blotting products. Geographically, organic growth was strongest in China, Europe and North America. The company also resolved most of its software implementation issues, which had negatively impacted third quarter 2015 results.